Title:
AKKERMANSIA GUANGXIENSIS CAPABLE OF RESISTING OXIDATION, REDUCING FAT AND INHIBITING TUMOR GROWTH, AND PRODUCT AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/066434
Kind Code:
A1
Abstract:
Disclosed in the invention are an Akkermania and a product and use thereof. The Akkermania is Akkermansia guangxiensis N21116 and N21169, and the accession numbers are respectively: GDMCC No: 62888 and GDMCC No: 62889. Akkermansia guangxiensis N21116 and N21169 are new species of Akkermania, have resistance to human intestinal fluid, and have the effects of resisting oxidation, inhibiting tumor cell growth, and losing weight and reducing fat.
More Like This:
| JP3864357 | PRODUCTION OF PURINE NUCLEOSIDE COMPOUND |
| JP2018514221 | Vitamin B12 production means and methods in Lemna aouki |
| WO/2005/073223 | METHOD OF STABILIZING MACROLIDE COMPOUND |
Inventors:
XIAO GUILONG (CN)
LUO WEIFEI (CN)
LU ZHILONG (CN)
WEI XINLI (CN)
MENG LILI (CN)
YIN MENG (CN)
LU ENQIU (CN)
PANG SHIFU (CN)
LUO WEIFEI (CN)
LU ZHILONG (CN)
WEI XINLI (CN)
MENG LILI (CN)
YIN MENG (CN)
LU ENQIU (CN)
PANG SHIFU (CN)
Application Number:
PCT/CN2023/097509
Publication Date:
April 04, 2024
Filing Date:
May 31, 2023
Export Citation:
Assignee:
AIAGE LIFE SCIENCE CORP LTD (CN)
International Classes:
C12N1/20; A23K10/18; A23L33/105; A23L33/125; A23L33/135; A23L33/21; A61K8/99; A61K35/74; A61P3/06; A61P35/00; A61Q19/08; C12R1/01
Domestic Patent References:
| WO2019218401A1 | 2019-11-21 | |||
| WO2021060945A1 | 2021-04-01 | |||
| WO2020063646A1 | 2020-04-02 |
Foreign References:
| CN113862193A | 2021-12-31 | |||
| CN114832019A | 2022-08-02 |
Other References:
SHEN, NAN ET AL.: "Research Progress of Akkermansia muciniphila and its Mechanism in Obesity", BASIC & CLINICAL MEDICINE, vol. 38, no. 10, 31 October 2018 (2018-10-31), pages 1475 - 1479, XP055839562, ISSN: 1001-6325, DOI: 10.16352/j.issn.1001-6325.2018.10.023
Attorney, Agent or Firm:
JIAQUAN IP LAW (CN)
Download PDF: